Targeted Therapies for Lung Cancer 肺癌的標靶治療
2024/1/30
Non-small cell lung cancer (NSCLC) includes "adenocarcinoma," "squamous cell carcinoma," "large cell carcinoma," and "bronchoalveolar carcinoma." NSCLC often produces excessive levels of the epidermal growth factor receptor (EGFR), which contributes to the rapid growth, metastasis and drug resistance of cancer, resulting in sharp deterioration of the patient's condition.